Great read, valuation much much higher then current share price not taking into account all future deals and their values.
Seems pretty conservative but happy with 100%+ upside.
At the end of the day if one of testing companies think they are onto something really good with one of our peptides it would only make sence for them to take out the company out for x amount as its going to cost them $150 million + royalties once fully developed. This way they dont just have access to one peptide but the whole library for the same amount as it would have cost them for full milestone payments of just one peptide.
Great read, valuation much much higher then current share price...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |